Clinical outcome assessment in malignant glioma trials: measuring signs, symptoms, and functional limitations-Reference-Cited by-同舟云学术

Clinical outcome assessment in malignant glioma trials: measuring signs, symptoms, and functional limitations

Published:2016-03 Issue:suppl 2 Volume:18 Page:ii13-ii20
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:Neuro Oncol

Author:

Blakeley Jaishri O.,Coons Stephen Joel,Corboy John R.,Leidy Nancy Kline,Mendoza Tito R.,Wefel Jeffrey S.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/18/suppl_2/ii13/7498686/nov291.pdf

Reference55 articles.

1. FDA Center for Drug Evaluation and Research. Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims. http://www.fda.gov/downloads/Drugs/…/Guidances/UCM193282.pdf . 2009.

2. AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients

3. Phase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma

4. Pseudoprogression and Pseudoresponse: Imaging Challenges in the Assessment of Posttreatment Glioma

5. Marked Recovery of Vision in Children With Optic Pathway Gliomas Treated With Bevacizumab

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Do Measures of Real-World Physical Behavior Provide Insights Into the Well-Being and Physical Function of Cancer Survivors? Cross-Sectional Analysis;JMIR Cancer;2024-07-15

2. Functional paclitaxel-manganese-doped mesoporous silica nanoparticles for orthotopic brain glioma targeted therapy;Materials & Design;2024-02

3. Evidence and clinical considerations for cognitive rehabilitation;Neuropsychological and Psychosocial Foundations of Neuro-Oncology;2024

4. Do Measures of Real-World Physical Behavior Provide Insights Into the Well-Being and Physical Function of Cancer Survivors? Cross-Sectional Analysis (Preprint);2023-09-28

5. Baseline neurocognitive dysfunction is ubiquitous in intrinsic brain tumors– results from a large Indian cohort of patients and analysis of factors associated with domain-specific dysfunction;World Neurosurgery: X;2023-07